Jeffrey B. Kaplan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeffrey B. Kaplan has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Khalaf Kridin
Lűbeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
3 shared publications - Miloslav Sailer
Kane Biotech Inc., Winnipeg, MB R3T 6G2, Canada
3 shared publications Khalaf Kridin
Affiliations Laboratory for Skin Research, Institute for Medical Research, Galilee Medical Center, Nahariya, Israel, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
2 shared publicationsMary T. Callahan
Department of Biology, American University, Washington, DC, USA
2 shared publicationsMiloslav Sailer
Affiliation Kane Biotech, Inc., Winnipeg, Manitoba, Canada
2 shared publications- Narayanan Ramasubbu
Department of Oral Biology, Rutgers School of Dental Medicine, Newark, NJ, USA
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by MDPI AG in Microbiology Research
- Vol. 17 (11) , 216
Aerobic Cutibacterium acnes/Staphylococcus epidermidis Dual-Species Biofilms: Matrix Components In Vitro and Promotion of Cutibacterium acnes Growth on Human Skin Ex Vivo
Anaerobic Cutibacterium species and facultatively anaerobic coagulase-negative staphylococci (CoNS) are numerically abundant members of the human skin microbiota. Cutibacterium acnes can form biofilms under aerobic conditions when co-cultured with CoNS, a process that may facilitate its colonization of skin. Here, we characterized aerobic dual-species biofilms formed by C. acnes and CoNS in vitro. Aerobic growth of C. acnes in co-culture with CoNS occurred across multiple phylogenetically diverse C. acnes isolates. Moreover, C. acnes outcompeted CoNS, accounting for >90% of recovered CFUs after 5 d of aerobic co-culture. Mechanical disruption experiments showed that CoNS biofilms were readily detached by vortex agitation, whereas efficient detachment of C. acnes required sonication, suggesting stronger association with the biofilm matrix and/or culture vessel surface. All tested C. acnes strains produced detectable extracellular DNA (eDNA) and poly-N-acetylglucosamine (PNAG), and both components contributed to biofilm structural integrity and biocide resistance in aerobic dual-species biofilms. Finally, S. epidermidis supported aerobic growth of C. acnes on human skin explants ex vivo. These findings provide mechanistic insight into the ability of C. acnes to persist and dominate aerobic polymicrobial biofilms, identify eDNA and PNAG as potential targets for biofilm disruption, and suggest that cooperation with CoNS may facilitate C. acnes colonization and persistence on human skin.
- 28 October 2026
- Published by MDPI AG in Microbiology Research
- Vol. 17 (11) , 216
Open AccessAerobic Cutibacterium acnes/Staphylococcus epidermidis Dual-Species Biofilms: Matrix Components In Vitro and Promotion of Cutibacterium acnes Growth on Human Skin Ex Vivo
Anaerobic Cutibacterium species and facultatively anaerobic coagulase-negative staphylococci (CoNS) are numerically abundant members of the human skin microbiota. Cutibacterium acnes can form biofilms under aerobic conditions when co-cultured with CoNS, a process that may facilitate its colonization of skin. Here, we characterized aerobic dual-species biofilms formed by C. acnes and CoNS in vitro. Aerobic growth of C. acnes in co-culture with CoNS occurred across multiple phylogenetically diverse C. acnes isolates. Moreover, C. acnes outcompeted CoNS, accounting for >90% of recovered CFUs after 5 d of aerobic co-culture. Mechanical disruption experiments showed that CoNS biofilms were readily detached by vortex agitation, whereas efficient detachment of C. acnes required sonication, suggesting stronger association with the biofilm matrix and/or culture vessel surface. All tested C. acnes strains produced detectable extracellular DNA (eDNA) and poly-N-acetylglucosamine (PNAG), and both components contributed to biofilm structural integrity and biocide resistance in aerobic dual-species biofilms. Finally, S. epidermidis supported aerobic growth of C. acnes on human skin explants ex vivo. These findings provide mechanistic insight into the ability of C. acnes to persist and dominate aerobic polymicrobial biofilms, identify eDNA and PNAG as potential targets for biofilm disruption, and suggest that cooperation with CoNS may facilitate C. acnes colonization and persistence on human skin.
- Open Access
- 27 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320662
Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms
Cutibacterium acnes plays a key role in the development of acne vulgaris, with biofilm formation contributing to its persistence and resistance to antimicrobial treatments. A critical component of C. acnes biofilms is poly-N-acetylglucosamine (PNAG), an exopolysaccharide that facilitates both biofilm stability and biocide resistance. This study evaluated the efficacy of the PNAG-degrading enzyme dispersin B in enhancing the susceptibility of C. acnes biofilms to benzoyl peroxide (BP), a common anti-acne agent. Dual-species biofilms of C. acnes and Staphylococcus epidermidis, which has been shown to promote C. acnes biofilm growth under aerobic conditions, were cultivated in glass tubes and treated with dispersin B (5–80 µg/mL), BP (0.1–2.5%), or a combination of both. Dispersin B or BP alone reduced C. acnes colony-forming units (CFUs) by 1–2 log units. However, sequential treatment with dispersin B followed by BP achieved a synergistic effect, yielding a >6-log reduction in CFUs. Remarkably, concentrations as low as 5 µg/mL dispersin B combined with 0.5% BP efficiently eradicated C. acnes from the dual-species biofilms. These findings highlight the protective role of PNAG against BP and demonstrate the potential of dispersin B as an adjunctive therapy to enhance the efficacy of BP in acne treatment.
- 27 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320662
Open AccessSynergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms
Cutibacterium acnes plays a key role in the development of acne vulgaris, with biofilm formation contributing to its persistence and resistance to antimicrobial treatments. A critical component of C. acnes biofilms is poly-N-acetylglucosamine (PNAG), an exopolysaccharide that facilitates both biofilm stability and biocide resistance. This study evaluated the efficacy of the PNAG-degrading enzyme dispersin B in enhancing the susceptibility of C. acnes biofilms to benzoyl peroxide (BP), a common anti-acne agent. Dual-species biofilms of C. acnes and Staphylococcus epidermidis, which has been shown to promote C. acnes biofilm growth under aerobic conditions, were cultivated in glass tubes and treated with dispersin B (5–80 µg/mL), BP (0.1–2.5%), or a combination of both. Dispersin B or BP alone reduced C. acnes colony-forming units (CFUs) by 1–2 log units. However, sequential treatment with dispersin B followed by BP achieved a synergistic effect, yielding a >6-log reduction in CFUs. Remarkably, concentrations as low as 5 µg/mL dispersin B combined with 0.5% BP efficiently eradicated C. acnes from the dual-species biofilms. These findings highlight the protective role of PNAG against BP and demonstrate the potential of dispersin B as an adjunctive therapy to enhance the efficacy of BP in acne treatment.
- Open Access
- 16 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2601
Facultatively Anaerobic Staphylococci Enable Anaerobic Cutibacterium Species to Grow and Form Biofilms Under Aerobic Conditions
Facultatively anaerobic Staphylococcus spp. and anaerobic Cutibacterium spp. are among the most prominent bacteria on human skin. Although skin microbes generally grow as multispecies biofilms, few studies have investigated the interaction between staphylococci and Cutibacterium spp. in dual-species biofilms. Here, we measured the mono- and dual-species biofilm formation of four staphylococcal species (S. epidermidis, S. hominis, S. capitis, and S. aureus) and two Cutibacterium spp. (C. acnes and C. avidum) cultured in vitro under both aerobic and anaerobic conditions. The biofilms were quantitated by rinsing them to remove planktonic cells, detaching the biofilm bacteria via sonication, and enumerating the cells by dilution plating. When cultured alone, staphylococci formed biofilms under both aerobic and anaerobic conditions, whereas Cutibacterium spp. formed biofilms only under anaerobic conditions. In co-culture, staphylococcal biofilm formation was unaffected by the presence of Cutibacterium spp., regardless of oxygen availability. However, Cutibacterium spp. biofilm formation was significantly enhanced in the presence of staphylococci, enabling robust growth under both anaerobic and aerobic conditions. Fluorescence confocal microscopy of the aerobic dual-species biofilms suggested that staphylococci create anaerobic niches at the base of the biofilm where C. acnes can grow. These findings demonstrate that staphylococci facilitate the colonization of Cutibacterium spp. in oxygen-rich environments, potentially explaining their presence in high numbers on the oxygen-exposed stratum corneum.
- 16 December 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (12) , 2601
Open AccessFacultatively Anaerobic Staphylococci Enable Anaerobic Cutibacterium Species to Grow and Form Biofilms Under Aerobic Conditions
Facultatively anaerobic Staphylococcus spp. and anaerobic Cutibacterium spp. are among the most prominent bacteria on human skin. Although skin microbes generally grow as multispecies biofilms, few studies have investigated the interaction between staphylococci and Cutibacterium spp. in dual-species biofilms. Here, we measured the mono- and dual-species biofilm formation of four staphylococcal species (S. epidermidis, S. hominis, S. capitis, and S. aureus) and two Cutibacterium spp. (C. acnes and C. avidum) cultured in vitro under both aerobic and anaerobic conditions. The biofilms were quantitated by rinsing them to remove planktonic cells, detaching the biofilm bacteria via sonication, and enumerating the cells by dilution plating. When cultured alone, staphylococci formed biofilms under both aerobic and anaerobic conditions, whereas Cutibacterium spp. formed biofilms only under anaerobic conditions. In co-culture, staphylococcal biofilm formation was unaffected by the presence of Cutibacterium spp., regardless of oxygen availability. However, Cutibacterium spp. biofilm formation was significantly enhanced in the presence of staphylococci, enabling robust growth under both anaerobic and aerobic conditions. Fluorescence confocal microscopy of the aerobic dual-species biofilms suggested that staphylococci create anaerobic niches at the base of the biofilm where C. acnes can grow. These findings demonstrate that staphylococci facilitate the colonization of Cutibacterium spp. in oxygen-rich environments, potentially explaining their presence in high numbers on the oxygen-exposed stratum corneum.
- Open Access
Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme
The extracellular matrix of most bacterial biofilms contains polysaccharides, proteins, and nucleic acids. These biopolymers have been shown to mediate fundamental biofilm-related phenotypes including surface attachment, intercellular adhesion, and biocide resistance. Enzymes that degrade polymeric biofilm matrix components, including glycoside hydrolases, proteases, and nucleases, are useful tools for studying the structure and function of biofilm matrix components and are also being investigated as potential antibiofilm agents for clinical use. Dispersin B is a well-studied, broad-spectrum antibiofilm glycoside hydrolase produced by Aggregatibacter actinomycetemcomitans. Dispersin B degrades poly-N-acetylglucosamine, a biofilm matrix polysaccharide that mediates biofilm formation, stress tolerance, and biocide resistance in numerous Gram-negative and Gram-positive pathogens. Dispersin B has been shown to inhibit biofilm and pellicle formation; detach preformed biofilms; disaggregate bacterial flocs; sensitize preformed biofilms to detachment by enzymes, detergents, and metal chelators; and sensitize preformed biofilms to killing by antiseptics, antibiotics, bacteriophages, macrophages, and predatory bacteria. This review summarizes the results of nearly 100 in vitro and in vivo studies that have been carried out on dispersin B since its discovery 20 years ago. These include investigations into the biological function of the enzyme, its structure and mechanism of action, and its in vitro and in vivo antibiofilm activities against numerous bacterial species. Also discussed are potential clinical applications of dispersin B.
Open AccessAggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme
The extracellular matrix of most bacterial biofilms contains polysaccharides, proteins, and nucleic acids. These biopolymers have been shown to mediate fundamental biofilm-related phenotypes including surface attachment, intercellular adhesion, and biocide resistance. Enzymes that degrade polymeric biofilm matrix components, including glycoside hydrolases, proteases, and nucleases, are useful tools for studying the structure and function of biofilm matrix components and are also being investigated as potential antibiofilm agents for clinical use. Dispersin B is a well-studied, broad-spectrum antibiofilm glycoside hydrolase produced by Aggregatibacter actinomycetemcomitans. Dispersin B degrades poly-N-acetylglucosamine, a biofilm matrix polysaccharide that mediates biofilm formation, stress tolerance, and biocide resistance in numerous Gram-negative and Gram-positive pathogens. Dispersin B has been shown to inhibit biofilm and pellicle formation; detach preformed biofilms; disaggregate bacterial flocs; sensitize preformed biofilms to detachment by enzymes, detergents, and metal chelators; and sensitize preformed biofilms to killing by antiseptics, antibiotics, bacteriophages, macrophages, and predatory bacteria. This review summarizes the results of nearly 100 in vitro and in vivo studies that have been carried out on dispersin B since its discovery 20 years ago. These include investigations into the biological function of the enzyme, its structure and mechanism of action, and its in vitro and in vivo antibiofilm activities against numerous bacterial species. Also discussed are potential clinical applications of dispersin B.
- Open Access
- 23 July 2024
- Published by MDPI AG in Preprints.org
Aggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme
The extracellular matrix of most bacterial biofilms contains polysaccharides, proteins, and nucleic acids. These biopolymers have been shown to mediate fundamental biofilm-related phenotypes including surface attachment, intercellular adhesion, and biocide resistance. Enzymes that degrade polymeric biofilm matrix components, including glycoside hydrolases, proteases, and nucleases, are useful tools for studying the structure and function of biofilm matrix components and are also being investigated as potential antibiofilm agents for clinical use. Dispersin B is a well-studied, broad spectrum antibiofilm glycoside hydrolase produced by Aggregatibacter actinomycetemcomitans. Dispersin B degrades poly-N-acetylglucosamine, a biofilm matrix polysaccharide that mediates biofilm formation, stress tolerance, and biocide resistance in numerous Gram-negative and Gram-positive pathogens. Dispersin B has been shown to inhibit biofilm and pellicle formation; detach pre-formed biofilms; disaggregate bacterial flocs; sensitize pre-formed biofilms to detachment by enzymes, detergents, and metal chelators; and sensitize pre-formed biofilms to killing by antiseptics, antibiotics, bacteriophages, macrophages, and predatory bacteria. This review summarizes the results of nearly 100 in vitro and in vivo studies that have been carried out on dispersin B since it’s discovery 20 years ago. These include investigations into the biological function of the enzyme, it’s structure and mechanism of action, and its in vitro and in vivo antibiofilm activities against numerous bacterial species. Also discussed are potential clinical applications of dispersin B.
- 23 July 2024
- Published by MDPI AG in Preprints.org
Open AccessAggregatibacter actinomycetemcomitans Dispersin B: The Quintessential Antibiofilm Enzyme
The extracellular matrix of most bacterial biofilms contains polysaccharides, proteins, and nucleic acids. These biopolymers have been shown to mediate fundamental biofilm-related phenotypes including surface attachment, intercellular adhesion, and biocide resistance. Enzymes that degrade polymeric biofilm matrix components, including glycoside hydrolases, proteases, and nucleases, are useful tools for studying the structure and function of biofilm matrix components and are also being investigated as potential antibiofilm agents for clinical use. Dispersin B is a well-studied, broad spectrum antibiofilm glycoside hydrolase produced by Aggregatibacter actinomycetemcomitans. Dispersin B degrades poly-N-acetylglucosamine, a biofilm matrix polysaccharide that mediates biofilm formation, stress tolerance, and biocide resistance in numerous Gram-negative and Gram-positive pathogens. Dispersin B has been shown to inhibit biofilm and pellicle formation; detach pre-formed biofilms; disaggregate bacterial flocs; sensitize pre-formed biofilms to detachment by enzymes, detergents, and metal chelators; and sensitize pre-formed biofilms to killing by antiseptics, antibiotics, bacteriophages, macrophages, and predatory bacteria. This review summarizes the results of nearly 100 in vitro and in vivo studies that have been carried out on dispersin B since it’s discovery 20 years ago. These include investigations into the biological function of the enzyme, it’s structure and mechanism of action, and its in vitro and in vivo antibiofilm activities against numerous bacterial species. Also discussed are potential clinical applications of dispersin B.
- Open Access
- 29 May 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (5) , e0012624
Micrococcal nuclease regulates biofilm formation and dispersal in methicillin-resistant Staphylococcus aureus USA300
Biofilm formation is an important virulence factor for methicillin-resistant Staphylococcus aureus (MRSA). The extracellular matrix of MRSA biofilms contains significant amounts of double-stranded DNA that hold the biofilm together. MRSA cells secrete micrococcal nuclease (Nuc1), which degrades double-stranded DNA. In this study, we used standard methodologies to investigate the role of Nuc1 in MRSA biofilm formation and dispersal. We quantified biofilm formation and extracellular DNA (eDNA) levels in broth and agar cultures. In some experiments, cultures were supplemented with sub-MIC amoxicillin to induce biofilm formation. Biofilm erosion was quantitated by culturing biofilms on rods and enumerating detached colony-forming units (CFUs), and biofilm sloughing was investigated by perfusing biofilms cultured in glass tubes with fresh broth and measuring the sizes of the detached cell aggregates. We found that an MRSA nuc1 − mutant strain produced significantly more biofilm and more eDNA than a wild-type strain, both in the absence and presence of sub-MIC amoxicillin. nuc1 − mutant biofilms grown on rods detached significantly less than wild-type biofilms. Detachment was restored by exogenous DNase or complementing the nuc1 − mutant. In the sloughing assay, nuc1 − mutant biofilms released cell aggregates that were significantly larger than those released by wild-type biofilms. Our results suggest that Nuc1 modulates biofilm formation, biofilm detachment, and the sizes of detached cell aggregates. These processes may play a role in the spread and subsequent survival of MRSA biofilms during biofilm-related infections. IMPORTANCE: Infections caused by antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA) are a significant problem in hospitals. MRSA forms adherent biofilms on implanted medical devices such as catheters and breathing tubes. Bacteria can detach from biofilms on these devices and spread to other parts of the body such as the blood or lungs, where they can cause life-threatening infections. In this article, researchers show that MRSA secretes an enzyme known as thermonuclease that causes bacteria to detach from the biofilm. This is important because understanding the mechanism by which MRSA detaches from biofilms could lead to the development of procedures to mitigate the problem.
- 29 May 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (5) , e0012624
Open AccessMicrococcal nuclease regulates biofilm formation and dispersal in methicillin-resistant Staphylococcus aureus USA300
Biofilm formation is an important virulence factor for methicillin-resistant Staphylococcus aureus (MRSA). The extracellular matrix of MRSA biofilms contains significant amounts of double-stranded DNA that hold the biofilm together. MRSA cells secrete micrococcal nuclease (Nuc1), which degrades double-stranded DNA. In this study, we used standard methodologies to investigate the role of Nuc1 in MRSA biofilm formation and dispersal. We quantified biofilm formation and extracellular DNA (eDNA) levels in broth and agar cultures. In some experiments, cultures were supplemented with sub-MIC amoxicillin to induce biofilm formation. Biofilm erosion was quantitated by culturing biofilms on rods and enumerating detached colony-forming units (CFUs), and biofilm sloughing was investigated by perfusing biofilms cultured in glass tubes with fresh broth and measuring the sizes of the detached cell aggregates. We found that an MRSA nuc1 − mutant strain produced significantly more biofilm and more eDNA than a wild-type strain, both in the absence and presence of sub-MIC amoxicillin. nuc1 − mutant biofilms grown on rods detached significantly less than wild-type biofilms. Detachment was restored by exogenous DNase or complementing the nuc1 − mutant. In the sloughing assay, nuc1 − mutant biofilms released cell aggregates that were significantly larger than those released by wild-type biofilms. Our results suggest that Nuc1 modulates biofilm formation, biofilm detachment, and the sizes of detached cell aggregates. These processes may play a role in the spread and subsequent survival of MRSA biofilms during biofilm-related infections. IMPORTANCE: Infections caused by antibiotic-resistant bacteria known as methicillin-resistant Staphylococcus aureus (MRSA) are a significant problem in hospitals. MRSA forms adherent biofilms on implanted medical devices such as catheters and breathing tubes. Bacteria can detach from biofilms on these devices and spread to other parts of the body such as the blood or lungs, where they can cause life-threatening infections. In this article, researchers show that MRSA secretes an enzyme known as thermonuclease that causes bacteria to detach from the biofilm. This is important because understanding the mechanism by which MRSA detaches from biofilms could lead to the development of procedures to mitigate the problem.
- Open Access
- 1 May 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1386017
Poly-β-(1→6)-N-acetyl-D-glucosamine mediates surface attachment, biofilm formation, and biocide resistance in Cutibacterium acnes
Background: The commensal skin bacterium Cutibacterium acnes plays a role in the pathogenesis of acne vulgaris and also causes opportunistic infections of implanted medical devices due to its ability to form biofilms on biomaterial surfaces. Poly-β-(1→6)-N-acetyl-D-glucosamine (PNAG) is an extracellular polysaccharide that mediates biofilm formation and biocide resistance in a wide range of bacterial pathogens. The objective of this study was to determine whether C. acnes produces PNAG, and whether PNAG contributes to C. acnes biofilm formation and biocide resistance in vitro.Methods: PNAG was detected on the surface of C. acnes cells by fluorescence confocal microscopy using the antigen-specific human IgG1 monoclonal antibody F598. PNAG was detected in C. acnes biofilms by measuring the ability of the PNAG-specific glycosidase dispersin B to inhibit biofilm formation and sensitize biofilms to biocide killing.Results: Monoclonal antibody F598 bound to the surface of C. acnes cells. Dispersin B inhibited attachment of C. acnes cells to polystyrene rods, inhibited biofilm formation by C. acnes in glass and polypropylene tubes, and sensitized C. acnes biofilms to killing by benzoyl peroxide and tetracycline.Conclusion: C. acnes produces PNAG, and PNAG contributes to C. acnes biofilm formation and biocide resistance in vitro. PNAG may play a role in C. acnes skin colonization, biocide resistance, and virulence in vivo.
- 1 May 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1386017
Open AccessPoly-β-(1→6)-N-acetyl-D-glucosamine mediates surface attachment, biofilm formation, and biocide resistance in Cutibacterium acnes
Background: The commensal skin bacterium Cutibacterium acnes plays a role in the pathogenesis of acne vulgaris and also causes opportunistic infections of implanted medical devices due to its ability to form biofilms on biomaterial surfaces. Poly-β-(1→6)-N-acetyl-D-glucosamine (PNAG) is an extracellular polysaccharide that mediates biofilm formation and biocide resistance in a wide range of bacterial pathogens. The objective of this study was to determine whether C. acnes produces PNAG, and whether PNAG contributes to C. acnes biofilm formation and biocide resistance in vitro.Methods: PNAG was detected on the surface of C. acnes cells by fluorescence confocal microscopy using the antigen-specific human IgG1 monoclonal antibody F598. PNAG was detected in C. acnes biofilms by measuring the ability of the PNAG-specific glycosidase dispersin B to inhibit biofilm formation and sensitize biofilms to biocide killing.Results: Monoclonal antibody F598 bound to the surface of C. acnes cells. Dispersin B inhibited attachment of C. acnes cells to polystyrene rods, inhibited biofilm formation by C. acnes in glass and polypropylene tubes, and sensitized C. acnes biofilms to killing by benzoyl peroxide and tetracycline.Conclusion: C. acnes produces PNAG, and PNAG contributes to C. acnes biofilm formation and biocide resistance in vitro. PNAG may play a role in C. acnes skin colonization, biocide resistance, and virulence in vivo.
- Open Access
Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes biofilms
Cutibacterium acnes has been implicated in the pathogenesis of acne vulgaris. C. acnes forms biofilms which may contribute to host colonization and antimicrobial resistance. Poly- N -acetylglucosamine (PNAG) is an exopolysaccharide that mediates C. acnes biofilm formation. In this study we investigated the ability of the PNAG-degrading enzyme dispersin B to sensitize C. acnes biofilms to killing by the anti-acne agent benzoyl peroxide (BPO). C. acnes biofilms were cultured aerobically in glass tubes in the presence of Staphylococcus epidermidis which has been shown to stimulate C. acnes biofilm formation. Biofilms were treated with 5-80 μg/ml dispersin B and/or 0.1-2.5% BPO. Treatment of biofilms with dispersin B or BPO alone resulted in a 1-2 log reduction C. acnes CFUs, whereas treatment of biofilms with dispersin B followed by BPO resulted in a >6 log reduction in C. acnes CFUs. Concentrations as low as 5 μg/ml dispersin B and 0.5% BPO efficiently eradicated C. acnes from the dual-species biofilm. Our findings confirm that PNAG protects C. acnes from benzoyl peroxide killing and demonstrate that dispersin B and BPO act synergistically to kill C. acnes biofilm cells. Dispersin B may be a useful adjunct to BPO for the treatment and prevention of acne.
Open AccessSynergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes biofilms
Cutibacterium acnes has been implicated in the pathogenesis of acne vulgaris. C. acnes forms biofilms which may contribute to host colonization and antimicrobial resistance. Poly- N -acetylglucosamine (PNAG) is an exopolysaccharide that mediates C. acnes biofilm formation. In this study we investigated the ability of the PNAG-degrading enzyme dispersin B to sensitize C. acnes biofilms to killing by the anti-acne agent benzoyl peroxide (BPO). C. acnes biofilms were cultured aerobically in glass tubes in the presence of Staphylococcus epidermidis which has been shown to stimulate C. acnes biofilm formation. Biofilms were treated with 5-80 μg/ml dispersin B and/or 0.1-2.5% BPO. Treatment of biofilms with dispersin B or BPO alone resulted in a 1-2 log reduction C. acnes CFUs, whereas treatment of biofilms with dispersin B followed by BPO resulted in a >6 log reduction in C. acnes CFUs. Concentrations as low as 5 μg/ml dispersin B and 0.5% BPO efficiently eradicated C. acnes from the dual-species biofilm. Our findings confirm that PNAG protects C. acnes from benzoyl peroxide killing and demonstrate that dispersin B and BPO act synergistically to kill C. acnes biofilm cells. Dispersin B may be a useful adjunct to BPO for the treatment and prevention of acne.
- Open Access
Staphylococcus epidermidis enables Cutibacterium acnes to form biofilms under aerobic conditions
Staphylococcus epidermidis and Cutibacterium acnes are among the most abundant members of the human skin microbiome. Both species are associated with skin health and disease. Although skin microbes typically grow in surface-associated biofilms, few studies on the interaction between S. epidermidis and C. acnes in biofilms have been reported. In the present study we measured the ability of S. epidermidis and C. acnes , either individually or jointly, to form biofilms in glass culture tubes. Since S. epidermidis is a facultative anaerobe and C. acnes is an aerotolerant anaerobe, tubes were incubated both aerobically and anaerobically to assess the role of atmosphere in biofilm forma4on. When cultured individually, we found that S. epidermidis formed biofilms under both aerobic and anaerobic conditions, whereas C. acnes formed biofilms only under aerobic conditions. When co-cultured, the presence of C. acnes had no effect on S. epidermidis biofilm formation under either aerobic or anaerobic conditions. However, the presence of S. epidermidis significantly enhanced the growth of C. acnes biofilms under anaerobic conditions and enabled C. acnes to form biofilms under aerobic condi2ons. This finding may be clinically relevant to the interaction between S. epidermidis and C. acnes on human skin.
Open AccessStaphylococcus epidermidis enables Cutibacterium acnes to form biofilms under aerobic conditions
Staphylococcus epidermidis and Cutibacterium acnes are among the most abundant members of the human skin microbiome. Both species are associated with skin health and disease. Although skin microbes typically grow in surface-associated biofilms, few studies on the interaction between S. epidermidis and C. acnes in biofilms have been reported. In the present study we measured the ability of S. epidermidis and C. acnes , either individually or jointly, to form biofilms in glass culture tubes. Since S. epidermidis is a facultative anaerobe and C. acnes is an aerotolerant anaerobe, tubes were incubated both aerobically and anaerobically to assess the role of atmosphere in biofilm forma4on. When cultured individually, we found that S. epidermidis formed biofilms under both aerobic and anaerobic conditions, whereas C. acnes formed biofilms only under aerobic conditions. When co-cultured, the presence of C. acnes had no effect on S. epidermidis biofilm formation under either aerobic or anaerobic conditions. However, the presence of S. epidermidis significantly enhanced the growth of C. acnes biofilms under anaerobic conditions and enabled C. acnes to form biofilms under aerobic condi2ons. This finding may be clinically relevant to the interaction between S. epidermidis and C. acnes on human skin.
- Open Access
Poly- N -acetylglucosamine mediates Cutibacterium acnes biofilm formation and biocide resistance
Biofilm formation likely plays an important role in the pathogenesis of implant-related infections caused by Cutibacterium acnes . Biofilms protect bacteria from antimicrobials and host defenses which makes biofilm-related infections difficult to treat. Here we demonstrate that the exopolysaccharide poly- N -acetylglucosamine (PNAG) contributes to C. acnes biofilm formation in vitro . By treating C. acnes cells and biofilms with the PNAG-degrading enzyme dispersin B, we found that PNAG mediates the attachment of C. acnes cells to polystyrene rods and the formation C. acnes biofilms in glass and polypropylene tubes. We further show that PNAG protects C. acnes biofilm cells from killing by tetracycline and benzoyl peroxide. PNAG may play an important role in biofilm formation, antibiotic tolerance, and virulence in this opportunistic pathogen.
Open AccessPoly- N -acetylglucosamine mediates Cutibacterium acnes biofilm formation and biocide resistance
Biofilm formation likely plays an important role in the pathogenesis of implant-related infections caused by Cutibacterium acnes . Biofilms protect bacteria from antimicrobials and host defenses which makes biofilm-related infections difficult to treat. Here we demonstrate that the exopolysaccharide poly- N -acetylglucosamine (PNAG) contributes to C. acnes biofilm formation in vitro . By treating C. acnes cells and biofilms with the PNAG-degrading enzyme dispersin B, we found that PNAG mediates the attachment of C. acnes cells to polystyrene rods and the formation C. acnes biofilms in glass and polypropylene tubes. We further show that PNAG protects C. acnes biofilm cells from killing by tetracycline and benzoyl peroxide. PNAG may play an important role in biofilm formation, antibiotic tolerance, and virulence in this opportunistic pathogen.